June 20, 2018
Accenture Secures Frost & Sullivan Market Leadership Award for Real-world Evidence Enterprise Solutions

NEW YORK; June 20, 2018 – Accenture is the recipient of the 2018 Frost & Sullivan North American Market Leadership Award for real-world evidence (RWE) enterprise solutions.
This is the first time Accenture has secured the market leadership award. It is presented each year to a company that has demonstrated significant growth in its industry, has identified emerging trends before they became the standard in the marketplace, and has created advanced technologies that will catalyze and transform the industry.
Piyush Bansal, senior industry analyst, F&S said, “Accenture has been at the forefront of developing data integration, population health analytics, predictive health analytics, and patient insight platforms. Its comprehensive end-to-end RWE solutions enable pharmaceutical companies to create new business models based on real world data outcomes. Accenture clearly differentiates itself by offering specific functions such as its proprietary database, gathering patient data and generating insights, identifying biomarkers for drug discovery, and providing predictive intelligence for drug discovery and trials.”

Frost & Sullivan presents @AccentureLifSci their Market Leadership Award for Real-world Evidence Enterprise Solutions

“Real-world data and evidence is one of the most exciting parts of life sciences today and is accelerating with broader application of artificial intelligence (AI), machine learning, and cognitive computing tools, said Jeff Elton, Ph.D., managing director in Accenture Life Sciences. “We are privileged to be guiding and collaborating with our clients on the adoption of technologies that drive better-informed care decisions, improved patient outcomes, and higher overall value for the health system. RWE and advanced technologies are catalyzing new fields such as cloud-based digital pathology, AI-enhanced medical image interpretation, and applied genomic solutions for research and clinical treatment selection. This strong endorsement of our capabilities validates the breadth and depth of our RWE experience.”
The report states: “Accenture is a well-known brand in life science IT and analytics solutions, and is widely recognized for its cutting-edge technology and functional expertise. Accenture has worked with nearly all of the top 10 global pharmaceutical companies and several leading biotechnology companies to support their RWE needs, and stays focused on providing innovative and reliable business-focused solutions. The company continually gathers insights about clients’ existing and future business requirements to update its solutions and remain ahead of other competitors in the enterprise RWE solutions market.”
For the purposes of this analysis, Frost & Sullivan followed a 10-step process to evaluate award candidates and assess their fit with best practices criteria. This includes a 360-degree view of industry challenges, trends, and issues by integrating all seven of Frost & Sullivan’s research methodologies that include, but are not limited to, successful growth strategies founded on a thorough understanding of market, technical, economic, financial, customer, best practices, and demographic analyses.
Click here to learn more about Accenture’s Life Sciences practice.
About Accenture
Accenture is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions – underpinned by the world’s largest delivery network – Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders. With approximately 442,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives. Visit us at www.accenture.com.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation, and leadership. The company’s Growth Partnership Service provides the CEO and the CEO’s Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages more than 50 years of experience in partnering with Global 1000 companies, emerging businesses, and the investment community from 45 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.
# # #
Cam Granstra
+1 312 693 5992